Evoke's sole treatment fails to evoke the FDA's confidence, as agency rejects Gimoti after flagging concerns last month - Endpoints News https://t.co/s6TIGllnRF
— IDRO (@IDROOhio) April 2, 2019
from Twitter https://twitter.com/IDROOhio
April 02, 2019 at 10:24AM
No comments:
Post a Comment